Clinical Trial

A Study of LY4064809 in Healthy Adult Participants

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to find out how much LY4064809 gets into the blood stream and how long it takes the body to get rid of it when it is given as two formulations. For each participant, the study will last about nine weeks. Participants will remain in the clinical research center for about one month.
Protocol Amendment History 1 change
critical Trial completed 2026-04-21
Trial Details
NCT Number NCT07339735
Lead Sponsor Eli Lilly and Company
Conditions Healthy Participants
Enrollment 24 participants
Start Date 2026-01-12
Primary Completion 2026-03-19 (estimated)
Study Completion 2026-03-19 (estimated)
Updated on ClinicalTrials.gov 2026-04-20